| Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ... MedRxiv, 2020.06. 22.20137273, 2020 | 11852* | 2020 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1476 | 2020 |
| Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... The Lancet infectious diseases 14 (6), 498-509, 2014 | 1021* | 2014 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 850* | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 842 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 745 | 2021 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 621 | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 500 | 2021 |
| BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults AC Davidson, S Banham, M Elliott, D Kennedy, C Gelder, A Glossop, ... Thorax 71 (Suppl 2), ii1-ii35, 2016 | 482* | 2016 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 448* | 2021 |
| Tissue penetration of antifungal agents T Felton, PF Troke, WW Hope Clinical Microbiology Reviews 1, 68-88, 2014 | 400 | 2014 |
| Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial RG Wunderink, EJ Giamarellos-Bourboulis, G Rahav, AJ Mathers, ... Infectious diseases and therapy 7 (4), 439-455, 2018 | 387 | 2018 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 309 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 240 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 235 | 2022 |
| Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19 ER Mann, M Menon, SB Knight, JE Konkel, C Jagger, TN Shaw, ... Science immunology 5 (51), eabd6197, 2020 | 216 | 2020 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 194 | 2021 |
| Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical … J Rello, C Solé-Lleonart, JJ Rouby, J Chastre, S Blot, G Poulakou, ... Clinical Microbiology and Infection 23 (9), 629-639, 2017 | 154 | 2017 |
| Efficacy and safety of posaconazole for chronic pulmonary aspergillosis TW Felton, C Baxter, CB Moore, SA Roberts, WW Hope, DW Denning Clinical infectious diseases 51 (12), 1383-1391, 2010 | 153 | 2010 |
| Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic … JJ McNamee, MA Gillies, NA Barrett, GD Perkins, W Tunnicliffe, D Young, ... Jama 326 (11), 1013-1023, 2021 | 148 | 2021 |
William HopeUniversity of Liverpool在 liverpool.ac.uk 的电子邮件经过验证
